Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Obesity is a chronic metabolic disease affecting adults and children worldwide. It has become one of the leading causes of death, as obesity is known to be the main risk factor for a number of non-communicable diseases, in particular type 2 diabetes. This close relationship led to the connotation ‘diabesity', highlighting the fact that the majority of individuals with diabetes are overweight or obese. Until today the BMI is still used to classify overweight and obesity. Since reduced muscle mass is highly prevalent throughout the BMI range, the measurement of body composition is strongly recommended. Moreover, it is essential for monitoring the course of weight reduction, which is part of every effective anti-obesity treatment. Weight reduction can be achieved via different weight loss strategies, including lifestyle intervention (diet and exercise), pharmacotherapy, or bariatric surgery. However, not all of these strategies are suitable for all patients, and any further needs should be considered. Besides, attention should also be drawn to concomitant therapies. These therapies may promote additional weight gain and further trigger the deterioration of blood glucose control. Thus, therapeutic strategies are warranted, which can be easily used for the management of obese patients with type 2 diabetes to achieve their glycemic and weight loss goals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity and T2D share key pathophysiological mechanisms and are both associated with increased risk for (i) metabolic complications [such as hypertension, dyslipidemia, obstructive sleep apnea (OSA) and metabolic-dysfunction associated steatotic liver disease (MASLD)] and (ii) cardiovascular disease [2,4].”
In the citing paper
“Obesity and T2D share key pathophysiological mechanisms and are both associated with increased risk for (i) metabolic complications [such as hypertension, dyslipidemia, obstructive sleep apnea (OSA) and metabolic-dysfunction associated steatotic liver disease (MASLD)] and (ii) cardiovascular disease [2,4].”
In the citing paper
“Obesity is the strongest risk factor for T2D and the obesity epidemic is heavily contributed to the rise of T2D prevalence, especially the increased rates of young-onset T2D [2].”
In the citing paper
“Obesity is the strongest risk factor for T2D and the obesity epidemic is heavily contributed to the rise of T2D prevalence, especially the increased rates of young-onset T2D [2].”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Self-citationGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Cited by
Items 101–200 of 430
Kiseleva, E. V., & Demidova, T. Y. (2021) · Obesity and metabolism · doi:10.14341/omet12758 · Cited by 21
Obesity and type 2 diabetes mellitus: insights from skeletal muscle extracellular matrix remodeling
Wu, L., & Coletta, D. K. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00154.2024 · Cited by 18
Why Are Obese People Predisposed to Severe Disease in Viral Respiratory Infections?
Aziz, R., Sherwani, A. Y., Mahri, S. A., Malik, S. S., & Mohammad, S. (2023) · Obesities · doi:10.3390/obesities3010005 · Cited by 18
Elashi, A. A., Toor, S. M., Umlai, U. I., Al-Sarraj, Y. A., Taheri, S., Suhre, K., Abou‐Samra, A., & Albagha, O. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01855-1 · Cited by 20
“Numerous studies have shown that obesity is a major risk factor of T2D onset and progression [6].”
BackgroundWang, Z., Qiu, C., Xu, L., Zhao, L., Liu, Y., Wu, X., Wang, Q., Liu, W., Li, K., Deng, H., et al. (2020) · Molecular Genetics and Genomics · doi:10.1007/s00438-020-01651-3 · Cited by 17
Role of Glycogen Synthase Kinase-3 in the Etiology of Type 2 Diabetes Mellitus: A Review
Bala, A., Roy, S., Das, D., Marturi, V., Mondal, C., Patra, S., Haldar, P. K., & Samajdar, G. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210730094225 · Cited by 17
Origins and functions of eosinophils in two non-mucosal tissues
Day, K. S., Rempel, L., Rossi, F. M. V., & Théret, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1368142 · Cited by 20
Discordance between postprandial plasma glucose measurement and continuous glucose monitoring
Barua, S., Wierzchowska-McNew, R. A., Deutz, N. E. P., & Sabharwal, A. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac181 · Cited by 17
Ghusn, W., Ma, P., Ikemiya, K., Hage, K., Abboud, D. M., Vierkant, R. A., Kendrick, M. L., Higa, K. D., Acosta, A. J., & Ghanem, O. M. (2023) · Surgical Endoscopy · doi:10.1007/s00464-023-10186-8 · Cited by 17
“Obesity is a complex and multifactorial disease that is associated with type-2 diabetes mellitus (T2DM) [1, 2].”
BackgroundNanotechnology and nucleic acid nanoparticles for treatment of metabolic disorders
Chu, D., Thị, H. V., Nguyen, T. T., Vu, T.-D., Thi, Y. V. N., Mani, I., Gohil, N., Bhattacharjee, G., Ramakrishna, S., & Singh, V. (2023) · OpenNano · doi:10.1016/j.onano.2023.100181 · Cited by 16
Salau, V. F., Erukainure, O. L., Aljoundi, A., Akintemi, E. O., Elamin, G., & Odewole, O. A. (2024) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2024.2352729 · Cited by 19
“Excessive consumption of carbohydrates and decreased physical exercise have been associated with insulin resistance, and high production of hepatic glucose and release of fatty acids (lipolysis) are its known major characteristics [5,6].”
BackgroundIs Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk?
Corrao, G., Compagnoni, M. M., Ronco, R., Merlino, L. G., Ciardullo, S., Perseghin, G., & Banfi, G. (2019) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000001089 · Cited by 15
“Although the approach can be adapted to any unmeasured confounder, we considered high BMI as a candidate confounder because it is particularly widespread in patients with diabetes [26] and is associated with both fracture risk [7, 34] and glycemic control [2].”
BackgroundJooste, B. R., Kolivas, D., Brukner, P., & Moschonis, G. (2023) · Nutrients · doi:10.3390/nu15204362 · Cited by 14
“Obesity is an important clinical risk factor for T2DM, as these two conditions are strongly linked and referred to as diabesity [11].”
BackgroundKotikalapudi, N., Sampath, S. J. P., Narayan, S. S., Bhonde, R. R., Nemani, H., Mungamuri, S. K., & Venkatesan, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-96121-0 · Cited by 17
Cypel, Y., Vogt, D. S., Maguen, S., Bernhard, P. A., Lowery, E. P., Culpepper, W. J., Armand-Gibbs, I., & Schneiderman, A. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102122 · Cited by 17
Riise, H. K. R., Graue, M., Igland, J., Birkeland, K. I., & Kolltveit, B. H. (2023) · BMC Family Practice · doi:10.1186/s12875-023-02100-x · Cited by 16
Pierret, A. C. S., Benton, M., Gupta, P. S., & Ismail, K. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02392-0 · Cited by 23
“Obesity and T2D are both major global health challenges [2] with occurring at least once a week for 3 months, and without any compensatory behaviour [ 11 ].”
Boye, K. S., Shinde, S., Kennedy-Martin, T., Robinson, S., & Thieu, V. T. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s328583 · Cited by 18
“Introduction A strong relationship exists between diabetes and overweight or obesity.(1) Estimates suggest that ~90% of people with type 2 diabetes (T2D) have overweight or obesity.”
BackgroundIsmaiel, A., Spînu, M., Socaciu, C., Budişan, L., Leucuta, D., Popa, S., Chiş, B. A., Berindan‐Neagoe, I., Olinic, D.-M., & Dumitrascu, D. L. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00182-7 · Cited by 16
“Obesity is known to be the primary risk factor for several non-communicable diseases, especially type 2 diabetes [41].”
BackgroundBoye, K. S., Shinde, S., Kennedy‐Martin, T., Robinson, S. J., & Thieu, V. T. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 14
Li, S., Li, S., Ding, J., & Zhou, W. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01142-z · Cited by 21
Zhao, F., Tomita, M., & Dutta, A. (2023) · Brain Sciences · doi:10.3390/brainsci13071099 · Cited by 15
“So, our study added evidence of impaired oxidative capacity in older adults with T2DM that needs combined strategy with obesity [132] with 150+ minutes/week moderate-intensity exercise and monitored with muscle oxygenation changes [15]—see Figure S4 in the Supplementary Materials for our exercise recommendation.”
BackgroundReport from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
Schnell, O., Battelino, T., Bergenstal, R. M., Blüher, M., Böhm, M., Brosius, F. C., Carr, R. D., Ceriello, A., Forst, T. M., Giorgino, F., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01481-0 · Cited by 17
“According to the World Health Organization (WHO), 44% of people with diabetes have overweight or obesity [3].”
MethodWang, Z., Hazlehurst, J., Subramanian, A., Tahrani, A. A., Hanif, W., Thomas, G. N., Singh, P., Wang, J., Sainsbury, C. A. R., Nirantharakumar, K., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.888924 · Cited by 15
“It is possible that increased mobilization of endothelial progenitor cells leading to better vascular function protects severely obese patients (29).”
BackgroundLi, B., Wan, L., Liu, T., & Zha, L. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1024786 · Cited by 18
Farhat, G. (2023) · Healthcare · doi:10.3390/healthcare11081123 · Cited by 19
“Whilst it is primarily caused by excess body weight, T2DM is exacerbated by poverty and lack of access to adequate health care [2,3].”
BackgroundAssociation of Obesity Indicators with Hypertension in Type 2 Diabetes Mellitus Patients
Chaudhary, G. M. D., Din, A. T. U., Chaudhary, F. M. D., Tanveer, A., Siddiqui, K. H., Din, A. T. U., Chaudhary, N. A., Chaudhary, S. M. D., Tameez-ud-din, A., & Nawaz, F. A. (2019) · Cureus · doi:10.7759/cureus.5050 · Cited by 18
Raźny, U., Góralska, J., Calder, P. C., Gruca, A., Childs, C. E., Kapusta, M., Słowińska-Solnica, K., Dembinska-Kiec, A., Solnica, B., & Malczewska-Malec, M. (2021) · Nutrients · doi:10.3390/nu13093096 · Cited by 16
“Weight loss exerts beneficial effects on health by improving metabolic parameters (serum triglyceride concentration, glucose tolerance and insulin sensitivity) as well as decreasing blood inflammatory markers and cardiovascular risk factors [3].”
BackgroundJain, S., & Jacobson, K. A. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102190 · Cited by 13
Muñoz‐Rodríguez, J. R., Agarrado, A., Martín‐Fernández, J., Salas, E., González‐Martín, C., & Alguacil, L. F. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.07.026 · Cited by 13
Estrada-Meza, J., Videlo, J., Bron, C., Saint-Béat, C., Silva, M., Duboeuf, F., Peyruchaud, O., Rajas, F., Mithieux, G., & Gautier‐Stein, A. (2021) · Endocrinology · doi:10.1210/endocr/bqab098 · Cited by 16
Tuccinardi, D., Zilich, R., Ponzani, P., Musacchio, N., Manicardi, V., Rocca, A., Pontremoli, R., Fioretto, P., Muscarà, A., Cianni, G. D., et al. (2025) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00251-7 · Cited by 12
“However, given the high prevalence of obesity among individuals with T2D [18], body mass index (BMI) may disproportionately influence treatment decisions.”
Glycaemia dynamics in gestational diabetes mellitus
Valero, P., Salas, R., Pardo, F., Cornejo, M., Fuentes, G., Vega, S., Grismaldo, A., Hillebrands, J., van der Beek, E. M., van Goor, H., et al. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130134 · Cited by 13
Selective aryl hydrocarbon receptor modulators can act as antidepressants in obese female mice
Debler, R. A., Madison, C. A., Hillbrick, L., Gallegos, P. L., Safe, S. H., Chapkin, R. S., & Eitan, S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.044 · Cited by 12
Complementary Approaches to Retinal Health Focusing on Diabetic Retinopathy
Rák, T., Kovács-Valasek, A., Pöstyéni, E., Csutak, A., & Gabriel, R. (2023) · Cells · doi:10.3390/cells12232699 · Cited by 13
“Daily exercise, or at least performing it two times a week, is rec‑ ommended to reduce insulin resistance, regardless of the type of diabetes [92,93].”
BackgroundResultCarretero‐Gómez, J., Ena, J., Arévalo‐Lorido, J. C., Ripoll, J. M. S., Carrasco-Sánchez, F. J., Gómez‐Huelgas, R., Soto, M. I. P., Delgado‐Lista, J., & Pérez‐Martínez, P. (2020) · Revista Clínica Española · doi:10.1016/j.rce.2020.06.008 · Cited by 28
Alberti, A., Schuelter‐Trevisol, F., Iser, B. P. M., Traebert, E., Freiberger, V., Ventura, L., Rezin, G. T., da Silva, B. B., Dallacosta, F. M., Grigollo, L. R., et al. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i20.5358 · Cited by 17
Does abdominal obesity influence immunological response to SARS-CoV-2 infection?
Sanchis‐Gomar, F., Lavie, C. J., Neeland, I. J., & Lippi, G. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1979392 · Cited by 12
Petryk, N., & Shevchenko, O. (2020) · Inflammation · doi:10.1007/s10753-020-01262-5 · Cited by 12
Izquierdo, A. G., Carreira, M. C., Rodríguez-Carnero, G., Fernández‐Quintela, A., Sueiro, A. M., Olmos, M. Á. M., Guzmán, G., de Luis, D. A., Pinhel, M. A. S., Nicoletti, C. F., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0630-7 · Cited by 13
Clinical outcomes in ‘diabese’ burn patients: A systematic review and meta-analysis
Born, L. J., Quiroga, L. H., Lagziel, T., Hultman, C. S., & Asif, M. (2021) · Burns · doi:10.1016/j.burns.2021.04.001 · Cited by 13
What Are the Clinical and Systemic Results of Periodontitis Treatment in Obese Individuals?
Silva‐Boghossian, C. M., & Dezonne, R. S. (2021) · Current Oral Health Reports · doi:10.1007/s40496-021-00295-5 · Cited by 14
Han, Y. W., Ye, X., Li, X., Yang, P., Wu, Y., Chen, L., Wu, H., & He, W. (2022) · International Journal of Nursing Practice · doi:10.1111/ijn.13126 · Cited by 10
“Overweight/obesity has multiple risks for patients living with T2DM (Leitner et al., 2017; Piche et al., 2020).”
BackgroundMemelink, R. G., Njemini, R., Kuil, M. J. J. D. B., Wopereis, S., den Bosch, J. D. V., Schoufour, J. D., Tieland, M., Weijs, P. J. M., & Bautmans, I. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112410 · Cited by 15
“To address these challenges, combined lifestyle interventions that include resistance exercise have the potential to preserve muscle mass during weight loss (Leitner et al., 2017; Mem-elink et al., 2020).”
Ponce‐España, E., Cruz‐Chamorro, I., Santos‐Sánchez, G., Álvarez‐López, A. I., Fernández-Santos, J. M., Pedroche, J., Millán-Linares, M. C., Bejarano, I., Lardone, P. J., & Carrillo‐Vico, A. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117198 · Cited by 16
Genetic Susceptibility of Type 2 Diabetes and Metabolic Syndrome
Ercegović, V., Džimbeg, M., & Gelemanović, A. (2025) · Diabetology · doi:10.3390/diabetology6020011 · Cited by 17
Ghusn, W., Zeineddine, J., Betancourt, R. S., Gajjar, A., Yang, W., Robertson, A. G., & Ghanem, O. M. (2025) · Medicina · doi:10.3390/medicina61020350 · Cited by 17
“Moreover, T2D is particularly more prevalent in patient with obesity (i.e., BMI > 30 kg/m 2 ) [5–7].”
Hameed, A., Raza, S. A., Khan, M. I., Baral, J., Adhikari, A., Nur‐e‐Alam, M., Ahmed, S., Al‐Rehaily, A. J., Ashraf, S., Ul‐Haq, Z., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109348 · Cited by 11
Fadheel, H. K., Kaftan, A. N., Naser, F. H., Hussain, M. K., Algenabi, A. H. A., Mohammad, H. J., & Al-Kashwan, T. A. J. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00283-z · Cited by 13
“Among the external risk factors are mainly obesity (BMI over 30), which demonstrate strong association with the development of insulin resistance [16].”
BackgroundHigh prevalence of obesity among women in urban Haiti: Findings from a population-based cohort
Dade, E., Metz, M., Pierre, J. L., Rouzier, V., Sufra, R., Fox, E., Preval, F., St‐Preux, S., Zephir, J. R., Ariste, W., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.976909 · Cited by 13
“Regardless the cause of these sex-differences in obesity, the extremely high rates of obesity in women is a major public health concern given the association of obesity and CVD risks (2, 3), as well as intergenerational impacts of obesity of women of reproductive age (33, 34).”
BackgroundLow glycaemic index or low glycaemic load diets for people with overweight or obesity
Chekima, K., Yan, S. W., Lee, S. W. H., Wong, T. Z., Noor, M. I., Ooi, Y. B. H., Metzendorf, M., & Lai, N. M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005105.pub3 · Cited by 19
Rathod, P., & Yadav, R. P. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01404-w · Cited by 12
“Lastly, bariatric surgery (weight loss surgery) is a direct weight loss approach for morbidly obese patients with body mass index ≥ 40 or peoples with BMI ≥ 35 [12].”
Anti-obesity and anti-diabetic effects of L-citrulline are sex-dependent
Bagheripour, F., Jeddi, S., Kashfi, K., & Ghasemi, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122432 · Cited by 14
Exploratory risk prediction of type II diabetes with isolation forests and novel biomarkers
Yousef, H., Feng, S. F., & Jelinek, H. F. (2024) · Scientific Reports · doi:10.1038/s41598-024-65044-x · Cited by 13
“In obese individuals, the release of non-esterified fatty acids from adipose tissue is believed to contribute to insulin resistance and β-cell dysfunction, with the term diabesity coined to illustrate the tight association between obesity and T2DM 57,58 .”
BackgroundHarris, C. L., Goldman, B. M., Gurkas, P., Butler, C., & Bookman, P. (2022) · Journal of Health Psychology · doi:10.1177/13591053211068974 · Cited by 15
“Obesity has a longstanding association with chronic diseases, including hypertension, type-2 diabetes, hypercholesterolemia, thyroid disease, sleep apnea, and some cancers (Chaker et al., 2017; Guh et al., 2009; Hall et al., 2015; Kyriacou et al., 2019; Leitner et al., 2017; Lucassen and Cizza, 2012; Seravalle and Gra…”
BackgroundFabricating 3-dimensional human brown adipose microtissues for transplantation studies
Wang, O., Li, H., Lin, H., Tian, M., Zhang, S., Duan, B., Chung, S., Zhang, C., Lian, X. L., Wang, Y., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.10.022 · Cited by 13
Modeling Obesity-Associated Ovarian Dysfunction in Drosophila
Liu, H., Li, J., Chang, X., He, F., & Ma, J. (2022) · Nutrients · doi:10.3390/nu14245365 · Cited by 13
“Meanwhile, around 50–75% of patients with PCOS are obese or have impaired insulin sensitivity [24,25], and obese females are at higher risk for fertility issues [26] and T2D [27].”
BackgroundAbnormal functional connectivity of the frontostriatal circuits in type 2 diabetes mellitus
Fu, Y., Gu, M., Wang, R., Xu, J., Sun, S., Zhang, H., Huang, D., Zhang, Z., Peng, F., & Lin, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1055172 · Cited by 9
“, excessive eating) is one of the typical clinical symptoms of T2DM and is closely linked to the epidemic of obesity (DeFronzo et al., 2015; Leitner et al., 2017).”
BackgroundGaweł, E., Hall, B., Siatkowski, S., Grabowska, A., & Zwierzchowska, A. (2024) · Nutrients · doi:10.3390/nu16030355 · Cited by 16
“These include cardiovascular disease [5], type 2 diabetes mellitus [6], non-alcoholic fatty liver disease [6], certain types of cancer [5] and mental disorders [7].”
BackgroundStarch Biosynthesis in Crop Plants
Tetlow, I. J. (2018) · Agronomy · doi:10.3390/agronomy8060081 · Cited by 12
“In addition, over-consumption of carbohydrate-rich foods in some parts of the world are leading to health epidemics such as obesity and type-two diabetes [5].”
BackgroundRozman, U., Mis, N. F., Kupirovič, U. P., Pravst, I., Kocbek, P., Strauss, M., & Turk, S. Š. (2021) · Journal of Health Population and Nutrition · doi:10.1186/s41043-021-00250-1 · Cited by 18
“Especially worrisome are obesity and type 2 diabetes, as they emerged as epidemics of modern societies [16, 17].”
BackgroundThe impact of body mass index on prognosis in patients with colon carcinoma
Fuchs, J. E., Schellerer, V. S., Brunner, M., Geppert, C. I., Grützmann, R., Weber, K., & Merkel, S. (2022) · International Journal of Colorectal Disease · doi:10.1007/s00384-022-04146-2 · Cited by 12
“These include cardiovascular disease [4], type 2 diabetes [5], metabolic syndrome [6], chronic kidney disease [7], chronic liver disease [8], and various types of * Susanne Merkel susanne.”
BackgroundInfluence of modern antidiabetic therapy on body weight in patients with type 2 diabetes mellitus
Салухов, В. В., Ilyinskaya, Т. A., & Minakov, A. A. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-1-39-52 · Cited by 14
RNA modification-related variants in genomic loci associated with body mass index
Wu, J., Wang, M., Han, L., Zhang, H., Lei, S., Zhang, Y., & Mo, X. (2022) · Human Genomics · doi:10.1186/s40246-022-00403-1 · Cited by 11
Quantitative Assessment of Pancreatic Fat by Quantitative CT in Type 2 Diabetes Mellitus
Li, Z., Yue, Q., Chen, Y., Zhang, Y., & Wan, Y. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s383783 · Cited by 9
Amin, H. D. M., Lazim, Z. S., & Al-Nashi, T. A. W. (2023) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/1158/4/042068 · Cited by 9
Lee, B., Cho, Y. M., Kim, S. G., Ko, S., Lim, S. K., Dahaoui, A., Jeong, J. S., Lim, H. J., & Yu, J. M. (2024) · Diabetes Therapy · doi:10.1007/s13300-023-01515-0 · Cited by 11
“T2D is a complex disease, with guidelines for management of diabetes promoting a person-alised, multifactorial treatment based on individual clinical characteristics and, besides optimising glycaemic control, also targeting obesity and other comorbidities [6–8].”
BackgroundBarge, S., Bhattacharya, A., Kumar, A., Das, S., Joishy, T. K., Mukherjee, A. K., Bhattacharjee, M. J., & Khan, M. R. (2024) · Food Frontiers · doi:10.1002/fft2.405 · Cited by 10
Targeted Nano-Based Systems for the Anti-Obesity Agent’s Delivery
Engin, A. B., Engin, A., & Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_22 · Cited by 10
Gong, J., Gao, F., Jiang, K., Xie, Q., Zhao, X., & Lei, Z. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14340 · Cited by 20
“It is notable that many complications, such as hypertension, cardiovascular diseases and nonalcoholic fatty liver disease, are very common in patients with diabetes and obesity 3,4 .”
Zhang, F.-S., Li, H., Yu, X. M., Song, Y., Ren, Y., Qian, X.-Z., Liu, J.-L., Li, W.-X., Huang, Y., & Gao, K. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i1.96032 · Cited by 11
Fecal microbiome analysis in patients with metabolic syndrome and type 2 diabetes
Sinisterra-Loaiza, L., Fernández-Edreira, D., Liñares-Blanco, J., Cepeda, A., Cardelle‐Cobas, A., & Fernandez-Lozano, C. (2025) · PeerJ · doi:10.7717/peerj.19108 · Cited by 12
Soltani-asl, M., Azimnasab-sorkhabi, P., Abolfathi, A., & Aghdam, Y. H. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0441 · Cited by 9
“Diabetes is one of the crucial endocrinology and metabolic diseases, which is caused bymalfunction of sugar and lipid metabolism [1, 2].”
BackgroundIs polypharmacy the future for pharmacological management of obesity?
Lafferty, R. A., Flatt, P. R., & Irwin, N. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100322 · Cited by 12
Comparison of the Impact of SGLT2-Inhibitors and Exenatide on Body Fat Composition
Agcakaya, E., Mutlu, H. H., Erbakan, A. N., & Sargın, M. (2023) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2023.03.308 · Cited by 13
Precision Medicine in Bariatric Procedures
Gala, K. S., Ghusn, W., & Acosta, A. J. (2024) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2024.03.004 · Cited by 10
Megalin Knockout Reduces SGLT2 Expression and Sensitizes to Western Diet-induced Kidney Injury
Youm, E. B., Shipman, K. E., Albalawy, W. N., Vandevender, A. M., SIPULA, I. J., Rbaibi, Y., Marciszyn, A. L., Lashway, J., Brown, E. E., Bondi, C. D., et al. (2024) · Function · doi:10.1093/function/zqae026 · Cited by 10
Cifre, M., Palou, A., & Oliver, P. (2020) · Nutrients · doi:10.3390/nu12082269 · Cited by 11
“Both obesity and metabolic syndrome play a crucial role in the origin of type 2 diabetes and cardiometabolic diseases [2].”
BackgroundOldfield, C. J., Moffatt, T. L., O’Hara, K. A., Xiang, B., Dolinsky, V. W., & Duhamel, T. A. (2021) · Physiological Reports · doi:10.14814/phy2.14961 · Cited by 9
“An unhealthy diet is one of the many factors linked to the development of obesity and type 2 diabetes (T2D) (Leitner et al., 2017).”
BackgroundSubias-Gusils, A., Álvarez-Monell, A., Boqué, N., Caimari, A., Bas-Prior, J. M. D., Mariné-Casadó, R., Solanas, M., & Escorihuela, R. M. (2021) · Nutrients · doi:10.3390/nu13124474 · Cited by 13
“The prevalence of overweight and obesity are escalating worldwide, along with Metabolic Syndrome (MetS) and the development of type-2 diabetes and cardiovascular diseases (CVD) [1,2].”
Ateteallah, H., Abd-Alla, A., Ateteallah, A. H., & Hassan, N. (2020) · Journal of Food and Dairy Sciences · doi:10.21608/jfds.2020.106364 · Cited by 9
Khoo, C. L., Chimoriya, R., Simmons, D. S., & Piya, M. K. (2022) · Australian Journal of Primary Health · doi:10.1071/py22180 · Cited by 8
Singh, A. K., Misra, A., Das, A. K., Behl, A., Srivastava, A., Paneerselvam, A., Chidambaram, B., Saboo, B., Sethi, B. K., Makkar, B. M., et al. (2023) · Journal of the Association of Physicians of India · doi:10.59556/japi.71.0422 · Cited by 12
“42 A biphasic weight loss pattern has been observed in clinical studies with SGLT2i: a substantial early impact, perhaps due to improved fluid excretion, was followed by a steady rise, with mean weights lower than baseline at any assessment.”
Li, N., Fan, Y., Zhou, J., Maimba, O. D., Zhang, L., & Li, Q. Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s250463 · Cited by 10
Morin, C., Javid, M., PATEL, Y. I., Flom, P. L., Andaz, C., Manasseh, D., Borgen, P. I., & Rojas, K. E. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08894-9 · Cited by 7
Benchoula, K., Vohra, M. S., Parhar, I. S., & Wong, E. H. (2022) · Metabolomics · doi:10.1007/s11306-022-01870-2 · Cited by 11
Tchonkouang, R. D., Antunes, M. D. C., & Vieira, M. M. C. (2022) · Physiology · doi:10.5772/intechopen.103933 · Cited by 18
Prior, S. J., Luccisano, S. P., Kilpatrick, M., & Murfet, G. O. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912894 · Cited by 8
“Managing obesity in people with type 2 diabetes through lifestyle modification, screening, and early detection of secondary complications can improve the management of diabetes-related complications [5].”
BackgroundFundoiano-Hershcovitz, ., Ritholz, M. D., Horwitz, D. L., Behar, E., Manejwala, O., & Goldstein, P. (2024) · Journal of Medical Internet Research · doi:10.2196/54940 · Cited by 7
“Obesity has become one of the leading causes of death, as it is known to be the main risk factor for several noncommunicable diseases, particularly T2D [4].”
Salamah, H. M., Marey, A., Elsayed, E., Hasan, M. T., Mahmoud, A., Abualkhair, K. A., Abo‐elnour, D. E., Abdelhaleem, I. A., & Abd‐ElGawad, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-46274-x · Cited by 10
“Together, they increase the individuals’ mortality risk sevenfold 18 .”
BackgroundAlramah, T., Cherian, P., Al‐Khairi, I., Abu‐Farha, M., Thanaraj, T. A., Albatineh, A. N., Safadi, F. F., Ali, H., Abdul‐Ghani, M. A., Tuomilehto, J. O., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1392675 · Cited by 10
Wang, Q., Zhang, J., Dou, W., Zeng, H., Shi, P., & Wu, J. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-02978-5 · Cited by 9
Hoffmann, K., Paczkowska, A., Bryl, W., Marzec, K., Raakow, J., Pross, M., Berghaus, R., Nowakowska, E., Kus, K., & Michalak, M. (2022) · Nutrients · doi:10.3390/nu14132775 · Cited by 9
“Moreover, owing to its close association with type 2 diabetes, the term “diabesity” was coined to reflect the combination of these two entities [6].”
BackgroundGüleroğlu, F. Y., Selvi, E., Bakırcı, I. T., Bafalı, İ. O., Atalmış, H. A., Dayan, M. Y., Ozmen, A. B., Yurtçu, N., Atas, B. S., Anayurt, E. Ö., et al. (2022) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-1937-1155 · Cited by 9
Xu, C., He, L., Zhang, J., Xu, L., Dong, J., & Liao, L. (2022) · Metabolites · doi:10.3390/metabo12100979 · Cited by 11
“T2DM works as a serious chronic metabolic disease that is characterized by insulin resistance (IR) and obesity, which accounts for 44% of diabetes cases [57,58].”
BackgroundWajid, M., Sattar, S., Khalid, F., & Masood, M. Q. (2023) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.1177/11795514231213568 · Cited by 7
Sweet, Fat and Salty: Snacks in Vending Machines in Health and Social Care Institutions in Slovenia
Rozman, U., Pravst, I., Kupirovič, U. P., Blaznik, U., Kocbek, P., & Turk, S. Š. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197059 · Cited by 13
Salau, V. F., Olofinsan, K. A., Mishra, A. P., Odewole, O. A., Ngnameko, C. R., & Matsabisa, M. G. (2024) · Plants · doi:10.3390/plants13141952 · Cited by 7
“Insulin resistance incapacitates peripheral tissues from utilizing glucose, thus leading to incessant hyperglycemia [4].”
BackgroundLiu, Q., Wen, Q., Lv, J., Shi, Z., Guo, Y., Pei, P., Du, H., Yang, L., Chen, Y., Zhang, X., et al. (2022) · Nutrients · doi:10.3390/nu14050980 · Cited by 11
“, the BMI and waist circumference) could serve as intermediate biomarkers in the analyses between the dietary pattern and diabetes [27].”
BackgroundChen, H., Ding, Y., & Shan, Y. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2468860 · Cited by 12
“Obesity remains the strongest risk factor for T2D, further intensifying the global burden of the disease [2].”
Metadata
- Authors
- Leitner, D. R., Frühbeck, G., Yumuk, V., Schindler, K., Micic, D., Woodward, E., & Toplak, H.
- Affiliations
- University of Graz (AT)
- Instituto de Salud Carlos III (ES)
- Istanbul University-Cerrahpaşa (TR)
- Medical University of Vienna (AT)
- European Association for the Study of Obesity (GB)
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 10
- Issue
- 5
- Pages
- 483-492
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC5741209
- OpenAlex
- W2762120405
- Cited by
- 431
- References
- 76
- Citations by year
- 2026: 16 · 2025: 51 · 2024: 67 · 2023: 80 · 2022: 76 · 2021: 68 · 2020: 51 · 2019: 14 · 2018: 8
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, type 2 diabetes, diabesity, body composition, weight loss, lifestyle intervention, pharmacotherapy, bariatric surgery, glycemic control
- MeSH terms
- Adult, Child, Combined Modality Therapy, Diabetes Mellitus, Type 2, Diet, Health Services Needs and Demand, Humans, Life Style, Obesity, Exercise, Comorbidity, Anti-Obesity Agents, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.